Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: Relation to vital genotype, cryoglobulinemia and response to interferon

Journal of Hepatology

Volumn 28, Issue 4, 1998, Pages 538-543

  Frangeul, Lionel ^a   Cresta, Pascale ^d   Perrin, Michele ^b   Duverlie, Gilles ^c   Khorsi, Hafida ^c   Musset, Lucile ^a   Opolon, Pierre ^b   Huraux, Jean Marie ^a   Lunel, Françoise ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Serv d'Hepato Gastro Enterologie   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Anti HCV antibodies; Cryoglobulinemia; Hepatitis C virus; Interferon; Interferon sensitivity determining region (ISDR); NS5A

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; VIRUS ANTIBODY;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CRYOGLOBULINEMIA; ENZYME ACTIVITY; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031961440     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80275-4     Document Type: Article

References (26)

1. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Simmonds P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol. 74:1993;2391-2399.
3. Abel G., Zhang Q.X., Agnello V. Hepatitis C virus infection in type II mixed cryolobulinemia. Arthritis Rheum. 36:1993;1341-1349.
4. Cacoub P., Lunel F., Musset L., Opolon P., Piette J.C. Hepatitis C virus and cryoglobulinemia. N Engl J Med. 328:1993;1121-1122.
5. Lunel F., Musset L., Cacoub P., Frangeul L., Cresta P., Perrin M., et al. Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology. 106:1994;1291-1300.
6. Frangeul L., Musset L., Cresta P., Cacoub P., Huraux J., Lunel F. Hepatitis C virus genotyes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol. 25:1996;427-432.
7. Diodati G., Bonetti P., Tagger A., Casarin C., Noventa F., Ribero M., et al. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C; evaluation of HCV genotypes during and after long-term follow-up. Dig Dis Sci. 39:1994;2497-2502.
8. Kobayashi Y., Watanabe S., Konishi M., Yokoi M., Kakehashi R., Kaito M., et al. Quantification and typing of serum hepatitis C RNA in patients with chronic hepatitis C treated with interferon β Hepatology. 18:1993;1319-1325.
9. Urdea M.S., Horn T., Fultz T.J. Branched DNA amplification multimers for the sensitive direct detection of human hepatitis viruses. Nucleic Acids Res Symp Sem. 24:1991;197-200.
10. Stuyver L., Rossau R., Wyseur A., Duhamel M., Vanderborgth B., Van Heuverswyn H., et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1102.
11. Musset L., Diemert M.C., Taibi F., Thi Huong Du L., Cacoub P., Leger J.M., et al. Characterization of cryoglobulins by immunoblotting. Clin Chem. 38:1992;798-802.
12. Maggi F., Vatteroni M., Pistello M., Avio C., Cecconi N., Panicucci F., et al. Serological reactivity and viral genotypes in hepatitis C virus infection. J Clin Microbiol. 33:1995;209-211.
13. Alonso C., Qu D., Lamelin J., Sanjosé S.d., Vitvitski L., Li J., et al. Serological responses to different genotypes of hepatitis C virus in France. J Clin Microbiol. 32:1994;211-222.
14. Puoti M., Zonaro A., Ravaggi A., Marin M., Castelnuovo F., Cariani E. Hepatitis C virus RNA antibody response in the clinical course of acute hepatitis C virus infection. Hepatology. 16:1992;877-881.
15. Martinot-Peignoux M., Marcellin P., Pouteau M., Castelnau C., Boyer N., Poliquin M., et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alpha therapy in chronic hepatitis C. Hepatology. 22:1995;1050-1056.
16. Nousbaum J.B., Pol S., Nalpas B., Landais P., Berthelot P., Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 122:1995;161-168.
17. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b - sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest. 96:1995;224-230.
18. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., et al. Mutation in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 334:1996;77-81.
19. Niiyama G., Kimura T., Mitani K., Tsugeno H., Sengoku N., Kinoyama S., et al. Mutations in the nonstructural protein 5A gene in chronic hepatitis C virus 1b infection patients with interferon treatment [abstract]. Hepatology. 24:1996;164.
20. Hayashi S., Masaki N., Isoo N., Shimizu K., Ohhara H., Sekigawa K., et al. Mutation in the NS5A region may predict effects of interferon treatment in chronic hepatitis C with genotype 1b [abstract]. Hepatology. 4:1996;126. Suppl.
21. Kurosaki M., Enomoto N., Ikeda T., Tozuka S., Marumo F., Sato C. Analysis of amino acid residues 2209 to 2248 of NS5A of HCV-1b in relation to the response to interferon beta therapy. Hepatology. 25:1997;750-753.
22. Murakami T., Enomoto N., Asahina Y., Izumi N., Marumo F., Sato C. Mutations in NS5A region and response to interferon in HCV genotype 2 infection [abstract]. Hepatology. 24:1996;155.
23. Gale J.R., Korth M.J., Tang N.M., Tan S.L., Hopkins D.A., Dever T.E., et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology. 230:1997;217-227.
24. Khorsi H., Castelain S., Wyseur A., Izopet J., Canva V., Rombout A., et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. Hepatol. 27:1997;72-77.
25. Zeuzem S., Lee J.-H., Roth W.K. Mutation in the NS5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology. 25:1997;740-744.
26. Squadrito G., Leone F., Sartori M., Nalpas B., Berthelot P., Raimondo G., et al. Mutations in the nonstructural 5A region of hepatitis C virus and response to interferon alfa. Gastroenterology. 113:1997;567-572.